| Insider | Title | Company | Date | Price | Return | Shares | Value |
|---|---|---|---|---|---|---|---|
| Katabi Maha | Non-Executive Director | Vera Therapeutics, Inc. (VERA) | 2024-01-30 | $31.00 | 23.1% | 161,290 | $4,999,990 |
| Katabi Maha | Non-Executive Director | RayzeBio, Inc. (RYZB) | 2023-09-19 | $18.00 | 247.2% | 472,222 | $8,499,996 |
| Katabi Maha | Non-Executive Director | Aerovate Therapeutics, Inc. (AVTE) | 2021-07-02 | $14.00 | -86.1% | 357,142 | $4,999,988 |
| Katabi Maha | Non-Executive Director | Vera Therapeutics, Inc. (VERA) | 2021-05-18 | $11.00 | 246.9% | 727,272 | $7,999,992 |
| Return | Profit / (loss) | Cost | |||||
| Total | 141.9% | $37,609,569 | $26,499,966 |